Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Cash T, Marachelian A, DuBois SG, Chi YY, Baregamyan A, Groshen SG, Jonus HC, Shamirian A, Crowley M, Goodarzian F, Acharya PT, Pawel B, Erbe AK, Shahi A, Zaborek J, Kennedy E, Asgharzadeh S, Villablanca JG, Pinto N, Weiss BD, Mosse YP, Desai AV, Macy ME, Granger M, Vo KT, Sondel PM, Matthay KK, Park JR, Goldsmith KC.J Clin Oncol. 2025 Jun 23:JCO2402612. doi: 10.1200/JCO-24-02612. Online ahead of print.PMID: 40549985
Management of Venous Thrombosis and Pulmonary Embolism During Cervical Brachytherapy.
Brower JV, Russo AL, Bradley KA, Fisher CM, Carlson R, Brubaker LW, Hagen PA, Leaf RK, Small W Jr, Klopp AH.Pract Radiat Oncol. 2025 Jun 14:S1879-8500(25)00119-5. doi: 10.1016/j.prro.2025.04.013. Online ahead of print.PMID: 40523472 No abstract available.
Advancing Proton FLASH Radiation Therapy: Innovations, Techniques, and Clinical Potentials.
Ma Y, Zhang T, Selvaraj B, Shen J, Wei S, Cheng C, Gao H, Poulsen PR, Li H, Diffenderfer E, Schuemann J, Lin L, Morris Z, Durkee B, Hesser J, Lin H, Simone CB 2nd, Kang M, Wu H.Int J Radiat Oncol Biol Phys. 2025 Jun 11:S0360-3016(25)00594-2. doi: 10.1016/j.ijrobp.2025.05.076. Online ahead of print.PMID: 40513679 Review.
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
DuBois SG, Moreno L, Anderson J, Asgharzadeh S, Bagatell R, Beck-Popovic M, Belle J, Berlanga P, Bird NJ, Chesler L, Durbin A, Eggert A, Eilers M, Federico SM, Fischer M, Gatz SA, George RE, George S, Goldsmith KC, Gray J, Heczey A, Irwin MS, Knox L, Lode HN, Ludwinski D, Macy ME, Majzner RG, Maris JM, Modak S, Molenaar JJ, Morgenstern DA, Mossé YP, Owens C, Reynolds CP, Rossig C, Schleiermacher G, Scott L, Sondel PM, Speleman F, van Noesel M, Westermann F, Wienke J, Wolpaw AJ, Park JR, Pearson ADJ.Pediatr Blood Cancer. 2025 Jun 12:e31831. doi: 10.1002/pbc.31831. Online ahead of print.PMID: 40509548 Review.
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer.
Bernard MJ, Ruiz A, Diaz JA, Nunley NM, Dove RN, Heering KY, Bopardikar S, Gallardo A, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Sharifi MN, Lang JM, Zhao SG, Haffner MC, Boutros PC, Christofk HR, Goldstein AS.bioRxiv [Preprint]. 2025 Jun 1:2025.05.28.656673. doi: 10.1101/2025.05.28.656673.PMID: 40502162 Free PMC article. Preprint.
Low-dose radiation by radiopharmaceutical therapy enhances GD2 TRAC-CAR T cell efficacy in localized neuroblastoma.
Sodji QH, Shea A, Cappabianca D, Forsberg MH, Eickhoff JC, Idrissou MB, Ollendorff AS, Kwon O, Ong IM, Hernandez R, Weichert J, Bednarz BP, Saha K, Sondel PM, Capitini CM, Morris ZS.Sci Adv. 2025 Jun 6;11(23):eadu4417. doi: 10.1126/sciadv.adu4417. Epub 2025 Jun 4.PMID: 40465728 Free PMC article.
FLASH Stereotactic Body Radiation Therapy for Spine Tumors Using a Single-Energy Proton Pristine Bragg Peak Delivery Technique.
Selvaraj B, Zhao X, Lin H, Shen J, Cheng C, Bookbinder A, Wu H, Zhai H, Choi JI, Chhabra AM, Hasan S, Simone CB 2nd, Yamada Y, Kang M.Adv Radiat Oncol. 2025 Apr 3;10(6):101776. doi: 10.1016/j.adro.2025.101776. eCollection 2025 Jun.PMID: 40416512 Free PMC article.
National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021.
Razavi A, Rooney MK, Fuller CD, Yu JB, Pfister NT, Thomas CR Jr, Buatti JM, Kamran SC, McGee HM, Yeboa DN, Kiess AP, Baschnagel AM, Kimple RJ.Adv Radiat Oncol. 2025 Apr 22;10(6):101767. doi: 10.1016/j.adro.2025.101767. eCollection 2025 Jun.PMID: 40330712 Free PMC article.
Embracing the Future of Clinical Trials in Radiation Therapy: An NRG Oncology CIRO Technology Retreat Whitepaper on Pioneering Technologies and AI-Driven Solutions.
Xiao Y, Benedict S, Cui Y, Glide-Hurst C, Graves S, Jia X, Kry SF, Li H, Lin L, Matuszak M, Newpower M, Paganetti H, Qi XS, Roncali E, Rong Y, Sgouros G, Simone CB 2nd, Sunderland JJ, Taylor PA, Tchelebi L, Weldon M, Zou JW, Wuthrick EJ, Machtay M, Le QT, Buchsbaum JC.Int J Radiat Oncol Biol Phys. 2025 Jun 1;122(2):443-457. doi: 10.1016/j.ijrobp.2025.01.006. Epub 2025 Jan 22.PMID: 39848295 Review.
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.
Uboha NV, Basree MM, Eickhoff JC, Deming DA, Matkowskyj K, Maloney J, McCarthy D, DeCamp M, LoConte N, Emmerich PB, Kraus S, Patel MA, Kratz JD, Lubner SJ, Hurst N, Bassetti MF.J Surg Oncol. 2025 Jun;131(7):1293-1301. doi: 10.1002/jso.28070. Epub 2025 Jan 5.PMID: 39757733 Free PMC article. Clinical Trial.
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants.
Frenkel M, Corban JE, Hujoel MLA, Morris Z, Raman S.Nat Biotechnol. 2025 Jun;43(6):996-1010. doi: 10.1038/s41587-024-02347-4. Epub 2024 Jul 24.PMID: 39048711